Hong Kong-listed Huajian Medical rises another 9% intraday, with a cumulative gain of over 200% in the past four weeks
According to ChainCatcher, Hong Kong-listed company Huajian Medical (01931.HK) surged another 9% during trading, with a cumulative increase of over 200% in the past four weeks. As of press time, the stock was up 7.3% at HKD 6.17, with a trading volume of HKD 23.32 million.
ChainCatcher previously reported that at the end of July, Huajian Medical announced the signing of a strategic cooperation framework agreement with BGI CoWin to jointly establish the Huajian-BGI CoWin Innovative Drug Intellectual Property Tokenization Fund (IVD-BGI CoWin).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CommBank State of the States ranks Queensland No. 1, ending Western Australia’s lead
Trump Energy Chief Says Fuel Export Ban Wouldn't Lower Prices
Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk
Crypto prices
More
